Employee Stock Ownership Plans: the §1042 capital gains deferral for C-corp sellers, the S-corp zero-federal-tax structure, the leveraged ESOP acquisition mechanism, and the OBBBA expansion of §1042 to S-corp stock in 2028
An Employee Stock Ownership Plan (ESOP) is a tax-qualified retirement plan, defined under IRC §4975(e)(7), that invests primarily in the stock of the sponsoring employer. For the employees, it is a retirement benefit that gives them ownership in the company. For the business owner, it is one of the most tax-advantaged succession and exit tools in the Code.
The ESOP sits at the intersection of retirement planning, corporate tax strategy, and business succession. A C-corporation owner who sells stock to an ESOP can defer capital gains tax indefinitely (and potentially permanently) under IRC §1042. An S-corporation that is 100% owned by an ESOP pays zero federal income tax on its ESOP-owned earnings, because the ESOP trust (a tax-exempt entity) receives the S-corp's pass-through income tax-free. And a leveraged ESOP can fund the entire acquisition with pre-tax dollars, making the purchase of the business itself tax-deductible.
The One Big Beautiful Bill Act (OBBBA), enacted July 4, 2025, added a new provision: beginning in 2028, S-corporation stock will qualify for a limited §1042 deferral (up to 10% of the gain). This expands the seller-side benefit to S-corp owners for the first time.
For business owners considering their exit or succession plan, the ESOP is worth understanding in detail. The tax benefits are substantial, the structure is well-established, and the regulatory framework (shared between the IRS and the Department of Labor) provides a clear path.
What an ESOP is
An ESOP is a qualified defined-contribution plan under IRC §401(a). It is structured as a stock bonus plan (or a combined stock bonus and money purchase plan) that must invest primarily in "qualifying employer securities" (the employer's own stock).
The employer establishes the ESOP trust, which holds the employer stock on behalf of the participating employees. Shares are allocated to individual employee accounts annually, typically based on compensation. Employees vest in their shares over a vesting schedule (typically 3 to 6 years, cliff or graded). When employees retire, terminate employment, become disabled, or die, they receive distributions of their vested shares (or the cash equivalent).
The IRS and the Department of Labor share jurisdiction over ESOPs. The IRS governs the tax-qualification requirements; the DOL governs the fiduciary and prohibited-transaction rules under ERISA (the Employee Retirement Income Security Act).
The §1042 capital gains deferral (C-corporation sellers)
The most powerful seller-side benefit is the §1042 rollover, which allows a C-corporation owner who sells stock to the ESOP to defer capital gains tax on the sale proceeds by reinvesting in "qualified replacement property" (QRP).
The requirements for the §1042 election:
The stock sold must be non-publicly-traded C-corporation stock. (S-corporation stock does not currently qualify, though the OBBBA extends a limited version beginning in 2028; see below.)
The ESOP must own at least 30% of each class of outstanding stock (or of the total value of all outstanding stock, excluding nonconvertible, nonvoting preferred stock) immediately after the sale.
The seller must have held the stock for at least 3 years before the sale.
The stock must not have been acquired through an employee stock plan or stock option arrangement under §83.
The seller must reinvest the sale proceeds in QRP within the period from 3 months before to 12 months after the sale (a 15-month window).
QRP is defined as stocks or bonds of domestic operating companies (not mutual funds, government bonds, or passive investment vehicles). The seller purchases QRP with the sale proceeds, and the capital gains tax is deferred as long as the seller holds the QRP.
The deferral can become permanent. If the seller holds the QRP until death, the QRP passes to the seller's heirs with a stepped-up basis under §1014, and the deferred gain is never recognized. This "hold until death" strategy is one of the most powerful capital-gains-avoidance tools in the Code.
Anti-allocation rules. Shares sold to the ESOP in a §1042 transaction cannot be allocated to the ESOP accounts of the seller, certain relatives of the seller (ancestors, siblings, spouse, lineal descendants), shareholders holding more than 25% of the company stock, or family members of those shareholders. These rules prevent the seller from getting the tax deferral and then receiving the same shares back through the ESOP.
Excise tax on early disposition. If the ESOP disposes of the shares within 3 years after the §1042 sale, the employer must pay a 10% excise tax on the disposition proceeds under §4978. This discourages the ESOP from quickly reselling the acquired stock.
The S-corporation zero-federal-tax structure
When an S-corporation is 100% owned by an ESOP, the ESOP's share of the S-corp's income is exempt from federal income tax. The mechanism: the ESOP trust is a tax-exempt entity under §501(a); as a shareholder of the S-corp, the ESOP trust receives the S-corp's pass-through income; because the trust is tax-exempt, it pays no tax on that income.
The result is that a 100% ESOP-owned S-corporation pays zero federal income tax on its earnings. This is one of the most powerful tax structures available to a closely held business. The company retains all of its pre-tax earnings, which can be reinvested, used to repay ESOP debt, or accumulated.
Even a partially ESOP-owned S-corporation benefits proportionally. If the ESOP owns 60% of the S-corp, 60% of the pass-through income flows to the tax-exempt ESOP trust and is not taxed; the remaining 40% is taxed to the other shareholders.
The S-corp ESOP structure has attracted scrutiny for potential abuse (concentrating ownership in a tax-exempt trust to avoid all federal income tax). Anti-abuse rules under §409(p) prevent the allocation of S-corp ESOP shares to a small group of insiders ("disqualified persons") who would effectively control the company and its tax-exempt income flow.
The OBBBA expansion: S-corp §1042 in 2028
Under current law, the §1042 capital gains deferral is available only for sales of C-corporation stock. S-corporation owners who sell to an ESOP do not get the §1042 deferral; they pay capital gains tax on the sale.
The OBBBA changes this beginning in 2028: S-corporation stock will qualify for a limited §1042 deferral, allowing sellers to defer up to 10% of the gain on the sale (rather than the 100% available for C-corp stock). The seller must reinvest the deferred proceeds in QRP under the same framework.
The 10% cap is modest compared to the C-corp 100% deferral, but it represents the first time S-corp owners have had any §1042 benefit. For a large sale, 10% deferral can still be a meaningful tax savings.
The leveraged ESOP
A leveraged ESOP borrows money to purchase employer stock. The mechanics:
The ESOP trust borrows money from a bank (or from the seller, in a seller-financed transaction).
The ESOP uses the borrowed funds to purchase employer stock from the existing shareholders.
The employer makes annual contributions to the ESOP trust to repay the loan (both principal and interest).
The employer's contributions are tax-deductible, effectively making the acquisition of the business itself tax-deductible.
For C-corporations, the deductibility is generous: the employer can deduct contributions to repay principal up to 25% of eligible payroll, plus interest, plus dividends used to repay the loan under §404(k). The dividend deduction under §404(k) is unique to ESOPs and allows C-corps to deduct dividends paid on ESOP-held stock when the dividends are used to repay the ESOP loan.
For S-corporations, the same 25% of eligible payroll limit applies to deductible contributions.
The leveraged ESOP effectively converts the purchase of the business from a non-deductible capital transaction to a deductible operating expense. The employer repays the loan with pre-tax dollars, which is a substantial advantage over a conventional sale-and-purchase transaction.
The valuation requirement
ESOP transactions must be conducted at fair market value as determined by a qualified, independent appraiser. The valuation requirement is strictly enforced by the Department of Labor, which investigates ESOP transactions for excessive valuations (which benefit the selling shareholders at the expense of the ESOP participants) and inadequate valuations (which harm the selling shareholders).
The ESOP trustee has a fiduciary duty to ensure the ESOP pays no more than fair market value for the stock. The independent appraiser's valuation is the anchor of the transaction; it must be conducted by a qualified professional using accepted valuation methodologies.
DOL enforcement actions and lawsuits challenging ESOP valuations are common. The valuation is the single most-litigated aspect of ESOP transactions. For sellers and trustees, engaging a qualified appraiser with ESOP experience is essential.
Employee benefits and distributions
For employees, the ESOP provides a retirement benefit in the form of employer stock:
Shares are allocated to individual accounts annually, typically based on compensation or a formula.
The annual addition limit is the lesser of $70,000 (2025) or 100% of the participant's compensation, per §415(c)(1).
Vesting schedules (typically 3-year cliff or 6-year graded) determine when the employee's shares are fully theirs.
At retirement, termination, disability, or death, the employee receives a distribution of vested shares (or cash equivalent).
Distributions are taxed as ordinary income, except that the "net unrealized appreciation" (NUA) on employer stock distributed in a lump sum is taxed at capital gains rates when the stock is later sold.
ESOP distributions can be rolled over to an IRA or another qualified plan tax-free under §402(c)(1).
Participants age 55 or older with at least 10 years of participation have diversification rights: they can diversify up to 25% of their ESOP account (50% in the final year before age 60) into other investments.
Coordination with other small business provisions
The ESOP framework coordinates with several other Halstonberg small business provisions:
Business succession planning is the primary context for ESOP transactions; the ESOP is one of the principal tools for transferring ownership to employees as a succession strategy.
§1202 QSBS and §1244 small business stock are alternative equity-related provisions that operate differently; §1202 provides gain exclusion, §1244 provides ordinary loss, and §1042 provides gain deferral through ESOP sales.
Defined benefit and cash balance plans are alternative retirement plan structures; ESOPs are defined-contribution plans that invest in employer stock rather than a diversified portfolio.
Choice of business entity affects the ESOP benefits: C-corps get the full §1042 deferral and the §404(k) dividend deduction; S-corps get the zero-federal-tax structure for ESOP-owned earnings and (beginning 2028) the limited 10% §1042 deferral.
Practical guidance
For business owners evaluating an ESOP:
The §1042 deferral is the centerpiece benefit for C-corp sellers. If you own a C-corporation and are planning to sell, the ESOP provides a tax-deferred (and potentially tax-free) exit that no other buyer can match. The 30% ownership threshold, the 3-year holding requirement, and the 15-month QRP reinvestment window are the key parameters.
For S-corp owners, the zero-federal-tax structure is the centerpiece. A 100% ESOP-owned S-corp pays no federal income tax on its earnings. Beginning in 2028, S-corp sellers will also get a limited 10% §1042 deferral.
The leveraged ESOP makes the acquisition tax-deductible. The employer's contributions to repay the ESOP loan are deductible, effectively converting the purchase into a deductible expense. For sellers who finance part of the sale, the loan interest is deductible by the employer as well.
Valuation is critical. The DOL scrutinizes ESOP valuations closely. Engage a qualified, independent appraiser with ESOP experience. An overvaluation benefits the seller at the employees' expense (and exposes the transaction to DOL challenge); an undervaluation shortchanges the seller.
The anti-allocation rules under §1042 and the anti-abuse rules under §409(p) for S-corps are consequential. The shares sold in a §1042 transaction cannot be allocated back to the seller or related parties. The §409(p) rules prevent concentration of S-corp ESOP benefits in a small group of insiders.
ESOP transactions involve substantial legal, tax, and valuation complexity. The typical transaction team includes an ESOP attorney, a tax advisor, an independent trustee, an independent appraiser, and a financing source (for leveraged transactions). For businesses with at least 20 to 30 employees and a consistent earnings track record, the ESOP can be a powerful tool; for smaller businesses or businesses with volatile earnings, the costs and complexity may outweigh the benefits.
ESOPs have been in the Code for decades, and the framework is well-established. For business owners who want to sell to their employees, retain the business's independence, defer capital gains, and create a tax-advantaged succession structure, the ESOP is one of the most effective tools available. The OBBBA's expansion of §1042 to S-corp stock in 2028 makes the structure even more attractive for the substantial number of businesses operating as S-corporations.